VIA
ELV icon

Vantage Investment Advisors’s Elevance Health ELV Stock Holding History

Vantage Investment Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-30
Closed -$4K – 816
2016
Q3 		$4K Hold
30
– – ﹤0.01% 620
2016
Q2 		$4K Hold
30
– – ﹤0.01% 642
2016
Q1 		$4K Hold
30
– – ﹤0.01% 643
2015
Q4 		$4K Hold
30
– – ﹤0.01% 632
2015
Q3 		$4K Buy
+30
New +$4.51K ﹤0.01% 647

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Vantage Investment Advisors's ELV Position: Q4 2016 in Review

Vantage Investment Advisors sold out of Elevance Health (ELV) in Q4 2016, closing a stake of 30 shares — an estimated $4K sold.

Vantage Investment Advisors first reported a position in ELV in Q3 2015 and held it in 5 quarters. The position peaked at $4K in Q3 2016. 784 funds tracked by Wall St. Rank hold ELV as of Q4 2016.

  • Vantage Investment Advisors reported no remaining Elevance Health position as of Q4 2016 after selling out during the quarter.
  • Vantage Investment Advisors sold 30 Elevance Health shares in Q4 2016, an estimated $4K.
  • Vantage Investment Advisors first reported a position in Elevance Health in Q3 2015 and held it in 5 quarters.
  • Vantage Investment Advisors's Elevance Health position peaked at $4K in Q3 2016.
  • 784 funds tracked by Wall St. Rank held Elevance Health as of Q4 2016.

Based on Vantage Investment Advisors's 13F filing for Q4 2016, filed 13 Feb 2017.